BCAB
BioAtla Inc.
$0.70
+$0.00(+0.66%)
37
Overall
40
Value
41
Tech
31
Quality
Market Cap
$36.52M
Volume
275.04K
52W Range
$0.24 - $2.53
Target Price
$10.00
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $300.0K | -- | -- | $11.0M | ||
| Total Revenue | $300.0K | -- | -- | $11.0M | ||
| GROSS PROFIT | ||||||
| Gross Profit | $300.0K | -- | -- | -- | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $96.7M | $108.1M | $129.7M | $84.9M | ||
| Research & Development | $58.3M | $79.3M | $103.7M | $63.1M | ||
| Research Expense | $58.3M | $79.3M | $103.7M | $63.1M | ||
| Selling, General & Administrative | $38.4M | $28.8M | $26.0M | $21.8M | ||
| General & Administrative Expenses | $38.4M | $28.8M | $26.0M | $21.8M | ||
| Salaries & Wages | $25.1M | $-1.1M | $-1.3M | $-294.0K | ||
| Other Operating Expenses | $-801.0K | $-946.0K | $-1.5M | $-980.0K | ||
| OPERATING INCOME | ||||||
| Operating income | $-96.4M | $-108.1M | $-129.7M | $-73.9M | ||
| EBITDA | $-94.1M | $-106.9M | $-122.2M | $-68.9M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $3.0K | -- | -- | -- | ||
| Intinc | $350.0K | $1.6M | $6.3M | $3.4M | ||
| Net Non-Operating Interest Income/Expense | $347.0K | $1.6M | $6.3M | $3.4M | ||
| Other Income/Expense | $-941.0K | $10.0K | $-87.0K | $-11.0M | ||
| Other Special Charges | $941.0K | $10.0K | -- | $11.0M | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-95.4M | $-108.1M | $-123.5M | $-69.8M | ||
| Pre-Tax Income | $-95.4M | $-106.5M | $-123.4M | $-69.8M | ||
| INCOME TAX | ||||||
| Tax Provision | $-2.1M | -- | -- | -- | ||
| NET INCOME | ||||||
| Net Income | $-95.4M | $-106.5M | $-123.5M | $-69.8M | ||
| Net Income (Continuing Operations) | $-95.4M | $-106.5M | $-123.5M | $-69.8M | ||
| Net Income (Discontinued Operations) | $-95.4M | $-106.5M | $-123.5M | $-69.8M | ||
| Net Income (Common Stockholders) | $-95.4M | $-106.5M | $-123.5M | $-69.8M | ||
| Normalized Income | -- | -- | -- | $-69.9M | ||
| TOTALS | ||||||
| Total Expenses | $96.7M | $108.1M | $129.7M | $84.9M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $34.6M | $38.9M | $47.8M | $48.6M | ||
| Average Shares Outstanding (Diluted) | -- | $38.9M | $47.8M | $48.6M | ||
| Shares Outstanding | $37.3M | $47.6M | $48.1M | $58.4M | ||
| Basic EPS | $-2.76 | $-2.74 | $-2.58 | $-1.44 | ||
| Basic EPS (Continuing Operations) | $-2.76 | $-2.74 | $-2.58 | $-1.44 | ||
| Diluted EPS | $-2.76 | $-2.74 | $-2.58 | $-1.44 | ||
| Diluted EPS (Continuing Operations) | -- | $-2.74 | $-2.58 | $-1.44 | ||
| OTHER METRICS | ||||||
| Minority Interests | $210.8M | -- | -- | -- | ||
| Other Gand A | $38.4M | $28.8M | $26.0M | $21.8M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAB | $0.70 | +0.7% | 275.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |